Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0F4NP
|
||||
Former ID |
DNCL003123
|
||||
Drug Name |
JNJ-17305600
|
||||
Indication | Schizophrenia [ICD9: 295; ICD10:F20] | Phase 1 | [548551] | ||
Company |
Johnson & Johnson Pharmaceutical Research & Development
|
||||
Target and Pathway | |||||
Target(s) | Sodium- and chloride-dependent glycine transporter 1 | Target Info | Inhibitor | [543979] | |
WikiPathways | NRF2 pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.